Pure Global AI
ANVISA registration 80105220326Active

ANTICARDIOLIPINA

ANVISA Registration Number: 80105220326KHAYROS DIAGNOSTICA FABRICACAO, COMERCIALIZACAO E DISTRIBUICAO DE PRODUTOS LTDADIYALAB ZJG BIOTECH CO., LTDRisk Class II
Verified
Device names
Technical name
ANTICARDIOLIPINA
View exact technical-name matches →
Commercial name
Anti-Cardiolipin IgG/IgM Assay Kit (Fluorescence Immunoassay)
View exact commercial-name matches →
Risk class
Class II
Registration details
Registration Number
80105220326
Process Number
25351148428202621
CNPJ
04299232000143
Company information
Registration Holder
KHAYROS DIAGNOSTICA FABRICACAO, COMERCIALIZACAO E DISTRIBUICAO DE PRODUTOS LTDA
Manufacturer
DIYALAB ZJG BIOTECH CO., LTD
Manufacturing Country
China
PT: CHINA, REPÚBLICA POPULAR
Dates and status
Publication Date
Sep 21, 2026
Status
Active
Official value: VIGENTE
About this record

Access comprehensive regulatory information for ANTICARDIOLIPINA in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80105220326 and manufactured by DIYALAB ZJG BIOTECH CO., LTD. The registration is held by KHAYROS DIAGNOSTICA FABRICACAO, COMERCIALIZACAO E DISTRIBUICAO DE PRODUTOS LTDA with validity until currently active (VIGENTE).

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.